Latest news
AI underused in trial conduct says ACRO - BioXconomyBioXconomy · Thu, 06 Aug 2026 08:31:19 GMTEyes on Asia: Axiom, Pathos AI, Samsung Biologics - BioXconomyBioXconomy · Tue, 04 Aug 2026 15:19:19 GMTHow CCOs can build crisis-capable compliance - BioXconomyBioXconomy · Thu, 30 Jul 2026 18:01:18 GMTAI impact on biopharma valuation stays murky - BioXconomyBioXconomy · Thu, 30 Jul 2026 14:29:14 GMT